Safety, efficacy and physiological actions of a lysine-free, arginine-rich formula to treat glutaryl-CoA dehydrogenase deficiency: Focus on cerebral amino acid influx
Open Access
- 31 October 2011
- journal article
- research article
- Published by Elsevier BV in Molecular Genetics and Metabolism
- Vol. 104 (1-2), 93-106
- https://doi.org/10.1016/j.ymgme.2011.07.003
Abstract
No abstract availableKeywords
Funding Information
- Franklin & Marshall College Eyler Fund
- John D. and Catherine T. McArthur Foundation
This publication has 62 references indexed in Scilit:
- Glutaric aciduria type I and methylmalonic aciduria: Simulation of cerebral import and export of accumulating neurotoxic dicarboxylic acids in in vitro models of the blood–brain barrier and the choroid plexusBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Classical maple syrup urine disease and brain development: Principles of management and formula designMolecular Genetics and Metabolism, 2010
- Genetic Mapping of Glutaric Aciduria, Type 3, to Chromosome 7 and Identification of Mutations in C7orf10American Journal of Human Genetics, 2008
- Glutaric aciduria type I: outcome following detection by newborn screeningJournal of Inherited Metabolic Disease, 2008
- Membrane translocation of glutaric acid and its derivativesJournal of Inherited Metabolic Disease, 2008
- Mechanism of age-dependent susceptibility and novel treatment strategy in glutaric acidemia type IJCI Insight, 2007
- ARGININE CHALLENGE UNRAVELS PERSISTENT DISTURBANCES OF UREA CYCLE AND GLUCONEOGENESIS IN ABSTINENT ALCOHOLICSAlcohol and Alcoholism, 2006
- The Role of Arginine in Infection and SepsisJournal of Parenteral and Enteral Nutrition, 2005
- Carnitine: transport and physiological functions in the brainMolecular Aspects of Medicine, 2004
- Neurosurgical Treatment for Hydrocephalus, Subdural Hematomas, and Arachnoid Cysts in Glutaric Aciduria Type 1Neuropediatrics, 1996